Roger Duvivier (standing), as a student at Einstein
There are certain people who enrich lives, shape careers and inspire excellence.
Einstein’s Dr. Roger Duvivier is one of those people.
From his upbringing in Haiti, Duvivier grew from a young man with a dream—who knew almost no English when he came to the U.S. at age 18—into an accomplished obstetrician/gynecologist, mentor and global health advocate. He graduated from Einstein in 1974 and went on to hold academic and clinical posts at Albert Einstein College of Medicine and Montefiore Medical Center, its University Hospital.
During his 40-year career, he has shown extraordinary leadership as a teacher, mentor and guide for students. His work for aid organizations in Guatemala has helped improve the detection of cervical cancer—a leading killer of women in that country.
Read more about Dr. Duvivier’s inspiring journey as a physician and global health leader.
There are five known species (or strains) of the deadly Ebola virus. Dr. Jonathan Lai, associate professor of biochemistry at Einstein, recently developed new antibodies that could one day be used as a therapy for the Sudan ebolavirus strain.
The Doctor’s Tablet recently sat down with Dr. Lai to discuss his latest study; his ongoing work to develop “broadly neutralizing antibodies” that could target more than one strain of Ebola and other filoviruses; and the current race to find a cure for Ebola. [click to continue…]
“September 1, 1939,” I said, narrowly eyeing the person beside me, scrunching my forehead in genuine scrutiny of the situation. Although I was not entirely certain of what was to come, the eternal optimist within geared up for an opportunity to go into raptures.
“Friday,” emerged his effortless reply.
And so it was.
Meet my younger brother. He has autism. [click to continue…]
A CDC image of an Ebola treatment center located in Guinea, West Africa
The current outbreak of Ebola in West Africa, which has led to at least 1,200 deaths, poses a number of ethical questions that are both pressing and unfamiliar.
There are currently no approved drugs to treat Ebola. However, new, untested treatments have been given to a few people during this latest outbreak, in the hopes of defeating a disease with a mortality rate of up to 90 percent.
The questions are: how will these therapies be distributed, and who will receive them first? [click to continue…]
Students learning about nutrition during a BODY club event in 2014.
When I was a child, one of my favorite sugary snacks was basically a small vat of frosting. It came with cookies for dunking. I won’t lie; some of that stuff is delicious, but with help from my family and what I learned in school, I came to appreciate healthier alternatives.
No question, it seems an uphill battle for many kids. Childhood obesity is epidemic, with more than one-third of U.S. kids and teens now classified as overweight or obese. And to make matters worse, kids in America watch, on average, between three and five fast-food ads every day. [click to continue…]